We identified one druggable molecular circuitry, based on IL-6/Signal Transducer and Activator of Transcription 3 (STAT3) axis that could be exploited to increase drug permeability across BBB, improving the delivery of chemotherapeutic drugs to GBM. Here, STAT3 is linked to glioblastoma.